Bromide

Bromide

SCHEMBL3712596

Br.Cc1ccccc1P

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67348 0.97
SCHEMBL30419542 0.94 TSHR (0.53)
Iodide SCHEMBL7953647 0.94
SCHEMBL5829989 0.94 TSHR (0.53)
SCHEMBL7947978 0.94
SCHEMBL9161372 0.94
Hydrochloric Acid SCHEMBL5076752 0.94
SCHEMBL3563862 0.94 TSHR (0.53)
SCHEMBL22472034 0.94
Benzene SCHEMBL27988746 0.94 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111518145-B Cyano-bridged metal organic compound with intramolecular magnetic transformation and preparation method and application thereof 荆楚理工学院 2023-06-20 CN disclosed
CN-110143857-B Synthetic method of semi-gossypol, gossypol and analogs thereof 华南理工大学 2021-11-30 CN disclosed
US-10202413-B2 Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors WASHINGTON UNIVERSITY (US) 2019-02-12 US disclosed
US-20160251391-A9 NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-09-01 US disclosed
EP-2956466-A1 NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS Washington University (US) 2015-12-23 EP disclosed
US-20150361125-A1 NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS UNIV WASHINGTON (US) 2015-12-17 US disclosed
WO-2014127201-A1 NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS WASHINGTON UNIVERSITY (US) 2014-08-21 WO disclosed
US-20130072727-A1 PROCESS FOR PRODUCING ETHYLENE GLYCOL CATALYZED BY IONIC LIQUID INSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES (CN) 2013-03-21 US disclosed
EP-2227482-A1 2',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS Pharmasset, Inc. (US) 2010-09-15 EP disclosed
WO-2009067409-A1 2',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS PHARMASSET, INC. (US) 2009-05-28 WO disclosed
CN-1108289-C Difluoroprostaglundin derivatives and their use ASAHI GLASS CO LTD (JP) 2003-05-14 CN disclosed
WO-2001038287-A1 ADDUCTS OF GLYCIDYLESTERS OF α,α-BRANCHED CARBOXYLIC ACIDS AND CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION RESOLUTION RESEARCH NEDERLAND B.V. (NL) 2001-05-31 WO disclosed
CN-1187486-A Difluoroprostaglundin Derivatives and their use ASAHI GLASS CO LTD (JP) 1998-07-15 CN disclosed
EP-0199564-B1 POLYHYDROXY POLYETHER, PROCESS FOR ITS PRODUCTION AND ITS USE MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-03-06 EP disclosed
US-4874859-A CROSSLINKING AGENT SOCIETE CHIMIQUE DES CHARBONNAGES (FR) 1989-10-17 US disclosed
US-4675373-A GAS BARRIER MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1987-06-23 US disclosed
EP-0199564-A2 Polyhydroxy polyether, process for its production and its use MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1986-10-29 EP disclosed